The pursuit of more data often leads to longer surveys, but this can come at a hidden cost.
Research solutions tailored for the unique needs of your business.
Tailored insights that speak directly to your business challenges.
Learn about the Angus Reid Group
Learn about our leadership team
Work with Angus Reid
News coverage and press releases
Let's have a conversation
Think you have what it takes to work with the best?
Benefit from research strategies crafted to address the unique dynamics of your industry.
White Papers, E-Books, Reports, Infographics & Articles
Will enough Americans take the vaccine when it’s offered to them?
"*" indicates required fields
As the rollout of COVID-19 vaccines begins in earnest across the United States, the question remains: will Americans take vaccines when they become available? To what extent will vaccine hesitancy factor in the campaign to vaccinate 382 million people? How do Americans feel about the logistics of the vaccine rollout? Which groups are more or less likely to resist vaccination?
A significant proportion of Americans are hesitant about the prospect of getting a COVID-19 vaccine. One-quarter (24%) of Americans state that they will not get vaccinated, while another eight per cent say they are not sure. This leaves, two-thirds of the adult population who will either get the vaccine as soon as it is available to them (43%), will get it but prefer to wait a little (17%) or who have already received it (8%).
Transform your customer experience strategy with actionable insights that drive growth and operational success.
The pursuit of more data often leads to longer surveys, but this can come at a hidden cost.
Angus Reid Group tracks Americans' purchasing behaviors amid high inflation and slow recovery.